Biechele Royce Advisors
- SEC CIK
- 0001730808
- Latest filing
- Oct 29, 2024
CVS holding history
CVS Health Corp in every 13F filed by Biechele Royce Advisors, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
CVS overviewAll 13F holders of CVSFull Q3 2024 holdings
- Shares (Q3 2024)
- 271,413
- Value
- $17.1M
- % of portfolio
- 5.6%
- Quarters held
- 15
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2024 | 271,413 | $17.1M | 5.6% | −2,933−1.1% | Reduced | Holders |
| Q2 2024 | 274,346 | $16.2M | 5.5% | +71,546+35.3% | Added | Holders |
| Q1 2024 | 202,800 | $16.2M | 5.4% | +3,513+1.8% | Added | Holders |
| Q4 2023 | 199,287 | $15.7M | 5.2% | +7,018+3.7% | Added | Holders |
| Q3 2023 | 192,269 | $13.4M | 4.9% | +6,232+3.3% | Added | Holders |
| Q2 2023 | 186,037 | $12.9M | 4.5% | +25,508+15.9% | Added | Holders |
| Q1 2023 | 160,529 | $11.9M | 4.4% | +11,864+8.0% | Added | Holders |
| Q4 2022 | 148,665 | $13.9M | 5.7% | +1,168+0.8% | Added | Holders |
| Q3 2022 | 147,497 | $14.1M | 6.6% | −1,405−0.9% | Reduced | Holders |
| Q2 2022 | 148,902 | $13.8M | 6.1% | −309−0.2% | Reduced | Holders |
| Q1 2022 | 149,211 | $15.1M | 6.0% | −2,956−1.9% | Reduced | Holders |
| Q4 2021 | 152,167 | $15.7M | 6.3% | +789+0.5% | Added | Holders |
| Q3 2021 | 151,378 | $12.8M | 5.7% | +10,414+7.4% | Added | Holders |
| Q2 2021 | 140,964 | $11.8M | 5.1% | +7,693+5.8% | Added | Holders |
| Q1 2021 | 133,271 | $10.0M | 5.0% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.